C
Conceivable Life Sciences
Current IVF labs are inefficient, expensive, often error prone and impossible to scale
About Conceivable Life Sciences
Conceivable Life Sciences is a biotechnology company focused on the fertility sector, specifically in-vitro fertilization (IVF). The company is developing what it describes as the world's first fully automated IVF laboratory. Its business model centers on leveraging a combination of artificial intelligence, robotics, advanced optics, and machine vision to automate the complex, multi-step process of creating embryos. This includes delicate procedures like single-cell surgery, which are traditionally performed manually by embryologists.
Read full description
The primary market for Conceivable Life Sciences is fertility clinics and healthcare providers offering IVF services. By automating the process, the company aims to increase the efficiency, standardization, and potentially the success rates of IVF treatments, while also making them more accessible. The company generates revenue by providing its automated lab technology and services to these clinics.
Recently, the company secured $18 million in a Series A funding round, which will be used to advance the development and commercialization of its platform. This indicates a business model that is currently in a growth and scaling phase, backed by venture capital.
Latest news
Press, funding announcements and product moves mentioning Conceivable Life Sciences.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Sep 2025 | $50M | $200M | Artis Ventures · Stride.VC · Advance Venture Partners · ACME Capital | ↗ |
| SERIES AOther financing | Jan 2025 | $18M | $100M | Muse Capital · Stride.VC · ACME Capital · Atlantic Health | ↗ |
Growth signals
Latest recorded traffic for Conceivable Life Sciences is 6.7K monthly website visits, up 109.4% over the last three months. Conceivable Life Sciences's team grew 24.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed6 investors entered at this stage
Coriolis Ventures
Stride.VC
ACME Capital
Black Opal Ventures
Future Positive Capital
Cadence Healthcare Ventures
Series A6 investors entered at this stage
Artis Ventures
Muse Capital
Atlantic Health
Time BioVentures
Scrub Capital
Advance Venture Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Conceivable Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Conceivable Life Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







